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CASE REPORT Open Access
Recovery from COVID-19 and acute
respiratory distress syndrome: the potential
role of an intensive care unit recovery
clinic: a case report
Kirby P. Mayer1* , Jamie L. Sturgill2, Anna G. Kalema2, Melissa K. Soper2, Sherif M. Seif2, Evan P. Cassity2,
Jimmi Hatton Kolpek3, Esther E. Dupont-Versteegden1, Ashley A. Montgomery-Yates2 and Peter E. Morris2
Abstract
Background: In this case report, we describe the trajectory of recovery of a young, healthy patient diagnosed with
coronavirus disease 2019 who developed acute respiratory distress syndrome. The purpose of this case report is to
highlight the potential role of intensive care unit recovery or follow-up clinics for patients surviving acute
hospitalization for coronavirus disease 2019.
Case presentation: Our patient was a 27-year-old Caucasian woman with a past medical history of asthma
transferred from a community hospital to our medical intensive care unit for acute hypoxic respiratory failure due
to bilateral pneumonia requiring mechanical ventilation (ratio of arterial oxygen partial pressure to fraction of
inspired oxygen, 180). On day 2 of her intensive care unit admission, reverse transcription–polymerase chain
reaction confirmed coronavirus disease 2019. Her clinical status gradually improved, and she was extubated on
intensive care unit day 5. She had a negative test result for coronavirus disease 2019 twice with repeated reverse
transcription–polymerase chain reaction before being discharged to home after 10 days in the intensive care unit.
Two weeks after intensive care unit discharge, the patient returned to our outpatient intensive care unit recovery
clinic. At follow-up, the patient endorsed significant fatigue and exhaustion with difficulty walking, minor issues
with sleep disruption, and periods of memory loss. She scored 10/12 on the short performance physical battery,
indicating good physical function. She did not have signs of anxiety, depression, or post-traumatic stress disorder
through self-report questionnaires. Clinically, she was considered at low risk of developing post–intensive care
syndrome, but she required follow-up services to assist in navigating the healthcare system, addressing remaining
symptoms, and promoting return to her pre–coronavirus disease 2019 societal role.
(Continued on next page)
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Conclusion: We present this case report to suggest that patients surviving coronavirus disease 2019 with
subsequent development of acute respiratory distress syndrome will require more intense intensive care unit
recovery follow-up. Patients with a higher degree of acute illness who also have pre-existing comorbidities and
those of older age who survive mechanical ventilation for coronavirus disease 2019 will require substantial post–
intensive care unit care to mitigate and treat post–intensive care syndrome, promote reintegration into the
community, and improve quality of life.
Keywords: COVID-19, Acute respiratory distress syndrome, Post-ICU follow-up, Physical function, Emotional health
Introduction
The emergence of the novel coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has
had a significant impact on patients, families, healthcare
systems, and communities. On March 11, 2020, the
World Health Organization officially declared the SARS-
CoV-2 virus outbreak a pandemic, officially known as
coronavirus disease 2019 (COVID-19) [1]. Patients diag-
nosed with COVID-19 have a broad range of presenta-
tions, from asymptomatic carriers to those with severe
critical illness with pneumonia, acute respiratory distress
syndrome (ARDS), and multiorgan failure. In this case
report, we describe the trajectory of recovery in a young,
healthy patient diagnosed with COVID-19 who devel-
oped ARDS. We suggest the importance of intensive
care unit (ICU) follow-up clinics to treat patients surviv-
ing mechanical ventilation or long-term ICU stay for
Covid-19.
Case presentation
Pre–COVID-19 diagnosis
Our patient was a 27-year-old Caucasian woman with a
past medical history of asthma. Her medical history was
otherwise unremarkable. She was employed in customer
service, was living with her husband, and denied a his-
tory of smoking or illicit drug use. She first noticed
symptoms of dry cough, body aches, and low-grade fever
(day 0). Four days later, she was diagnosed with bron-
chitis at a local community urgent treatment care center.
She was prescribed azithromycin, a bronchodilator
inhaler, and a steroid. She reported improvement of
symptoms initially, but within 2 days, she had notable
shortness of breath with minimal exertion with progres-
sive dry cough, pain, and perfuse sweating. She reported
significant shortness of breath when attempting to eat.
Subsequently, she decided to seek treatment at her local
community hospital. On day 7, she was admitted for
room air oxygen saturation reported between 84% and
88% and profound dyspnea. The result of her respiratory
viral panel was negative. She continued to have respira-
tory compromise with increasing oxygen requirements.
On day 8, she was intubated for acute hypoxic respira-
tory failure due to bilateral pneumonia and was
transferred to the medical intensive care unit (MICU) at
our academic medical center.
COVID-19 diagnosis and ICU clinical course
The patient remained intubated (70% fraction of inspired
oxygen with positive end-expiratory pressure [PEEP] of
10 cmH2O and ratio of arterial oxygen partial pressure
to fraction of inspired oxygen, 180) and minimally se-
dated (propofol and hydromorphone) for ARDS upon
admission to the MICU (day 8). Her chest radiograph
revealed bibasilar airspace disease (Fig. 1), and chest
computed tomography demonstrated bilateral lower lobe
consolidation and volume loss with atelectatic changes
in mild lower lung zones with scattered ground-glass
opacities in the upper lobe, mostly central, consistent
with bilateral pneumonia with lung volume loss and/or
atelectasis (Fig. 2). The patient’s Sequential Organ Fail-
ure Assessment score in the first 24 hours of ICU admis-
sion was 7. She was started on vancomycin, ceftriaxone,
and azithromycin for empiric coverage of community-
acquired pneumonia. Her brain natriuretic peptide and
lactate levels were within normal limits, and aerobic and
anaerobic blood cultures revealed no growth. The results
of testing for urine legionella and streptococcal pneumo-
nia antigens were also negative. The patient’s family re-
ported no travel history or exposure risk, but, given the
Fig. 1 Chest radiograph obtained on day 1 of admission to
intensive care unit revealed bibasilar airspace disease
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patient’s clinical symptoms, a test for COVID-19 was per-
formed. A positive test result for COVID-19 was con-
firmed on day 9. In addition to ARDS, she met the criteria
for a diagnosis of acute kidney injury (AKI; Kidney Disease
Improving Global Outcomes stage 1) on the basis of
decreased urine output and elevated creatinine level
(increased from 0.77mg/dl on first day in ICU to 1.45mg/
dl within 24 hours). Her liver enzyme levels were within
normal limits (C-reactive protein, 24.3 mg/L).
The patient’s clinical status gradually improved from
days 9–12 of her illness. She tolerated weaning of oxy-
gen and PEEP (Fig. 3). Her lung compliance was re-
ported by her primary physician as “good” with low
driving pressures (10–13 cmH2O). Her AKI improved
with increasing urine output. On day 13, sedative medi-
cations were weaned fully, and the patient passed a
spontaneous breathing trial. She was extubated to a
high-flow nasal cannula. The patient’s respiratory status
gradually improved with her being able to wean from
supplemental oxygen on day 15. On day 14, physical and
occupational therapy consults were performed, with the
patient demonstrating modified independence with mo-
bility and activities of daily of living. A physical therapist
and an occupational therapist provided education on ac-
tivity and exercise to promote strength and endurance.
On day 16, the patient had a negative test result for
Fig. 2 Chest computed tomography demonstrating bilateral lower
lobe consolidation, volume loss with atelectatic changes in mild
lower lung zones with scattered ground-glass opacities in upper
lobe mostly central, consistent with bilateral pneumonia with lung
volume loss and/or atelectasis
Fig. 3 COVID-19 clinical trajectory demonstrating change in supplemental oxygen required from first onset of symptoms to follow-up in the
intensive care unit recovery clinic with significant markers of patient case located on the horizontal axis. Adm Admission, appt Appointment,
Dc Discharge, FiO2 Fraction of inspired oxygen, ICU RC Intensive care unit recovery clinic, MIC Medical intensive care unit, NT Not tested,
OSH Outside hospital, Tx Transfer, UTC Urgent treatment center, VAS Visual analog scale
Mayer et al. Journal of Medical Case Reports          (2020) 14:161 Page 3 of 6
COVID-19 by reverse transcription–polymerase chain
reaction. A second test on day 18 confirmed the negative
test result, and the patient was discharged to home from
the MICU with her family later that afternoon.
Postdiagnosis and ICU recovery clinic
On day 31, the patient returned to the ICU recovery
clinic at our academic medical center. During her
follow-up appointment, she complained of general fa-
tigue and exhaustion. She stated she generally felt
“wiped out.” She expressed minor difficulty with walking
from the clinic garage, less than 500 feet from the clinic
lobby due to fatigue. Physically, the patient participated
in the short performance physical battery (SPPB), dem-
onstrating a 0.82 m/second gait speed on 4-m habitual
walk, 11.7 seconds to perform five times sit-to-stand
testing, and > 10 seconds in tandem stance (total score
10/12), thus demonstrating a minor slowing in gait
speed and minor difficulty with sit-to-stand perform-
ance, indicating minimal weakness in the lower extrem-
ities. The patient did have signs of mild depression (3/21
in the depression category of the Hospital Anxiety and
Depression Scale [HADS]) related to her situation or
memories of her illness, but her symptoms were not af-
fecting her day-to-day life or preventing her from enjoy-
ing things she previously enjoyed. She did not have
anxiety or signs of distress (HADS anxiety = 0/21, Im-
pact of Events Scale–Revised 7/88). The patient did
complain of short-term memory problems, which in-
cluded no memory of her first 2 days in the ICU. She re-
ported subsequent minor difficulty with daily short-term
memory and word finding since her hospital discharge.
She scored 29/30 on the Montreal Cognitive Assess-
ment, missing 1 point removed for the cube copy test,
which requires visual motor integration, depth percep-
tion, and spatial awareness. The patient also endorsed
minor difficulty with sleep, including a few nights of dis-
ordered sleep with frequent waking. She reported a score
of 85/100 on the EQ-5D visual analog scale.
On day 78, the patient reported returning to driving
and return to work with modifications due to fatigue, in-
cluding more frequent rest breaks, limited lifting of > 10
lb, and a stool to reduce time in prolonged standing.
On day 128 (approximately 4 months after discharge
from the hospital), the patient returned to the ICU re-
covery clinic. She reported significant improvement
overall, with only one episode of anxiety related to work
that was alleviated with deep breathing strategies. The
patient’s performance on physical, emotional, and cogni-
tive outcome measures had improved (Fig. 3). The pa-
tient continued to endorse reduced endurance and
periods of fatigue but was generally improved. At this
time point, the patient performed the 6-minute-walk test
(6MWD) with total distance ambulated 390 m, equating
to 64% of her percent predicted 6MWD [2]. She also
complained of insomnia, but she believed it to be unre-
lated to her ICU admission.
Discussion
We present a case report of a young, previously healthy
patient who developed ARDS due to COVID-19. The
purpose of this report is to demonstrate the clinical tra-
jectory and suggest the importance of ICU follow-up
visits with objective physical battery testing as well as
memory and cognitive testing. The patient responded
well to supportive treatment in the ICU, including
mechanical ventilation for 5 days and a total ICU stay of
9 days. On the basis of her Glasgow Coma Scale scores
(ranging from 6 to 11), she never required deep sedation;
in addition, on the basis of synchrony demonstrated with
the ventilator and ratios of arterial oxygen partial pres-
sure to fraction of inspired oxygen > 150, she did not re-
ceive neuromuscular blockers or undergo prone
positioning for ventilation–perfusion matching. Upon
awakening and extubation, she did have minor confusion
with memory deficits, but she had no delirium noted by
the primary physician. She did have AKI in the ICU,
which recovered quickly. It is important to note that pa-
tients who develop AKI, especially when severe, with
COVID-19 have increased secondary complications, in-
cluding higher risk of death [3]. Our patient, however,
continued to improve each day, with oxygen require-
ments gradually reducing, and she was discharged to
home after two negative quantitative polymerase chain
reaction test results.
Two weeks after discharge and 1 month after initial
presentation of symptoms, the patient returned for her
ICU recovery clinic appointment. Our ICU recovery
clinic consists of a transdisciplinary team that includes a
physician, an advanced practice registered nurse
(APRN), a pharmacist, a physical therapist, and a social
worker focused on improving quality of life after critical
illness, organizing subspecialty follow-up care, and pro-
moting rehabilitation. The primary objectives of ICU
follow-up or recovery clinics are to address and treat
post–intensive care syndrome (PICS) and help patients
reintegrate into their societal roles following an admis-
sion to the ICU [4–7]. Post-ICU follow-up clinics also
address traumatic emotional experiences of family mem-
bers and engage all parties to optimize outcomes [8–11].
We are aligned with the national ICU recovery clinic
movement organized by the Critical and Acute Illness
Recovery Organization. Within this framework, we de-
ploy a series of standardized evaluations for patients re-
covering from their ICU stay to assess emotional,
cognitive, and physical health as well as health-related
quality of life. Outcome measures assist in the develop-
ment of the plan of care and referral for interventions
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such as post-ICU mental health interventions. Given our
patient’s prior level of function (independent and
employed), younger age, and scores on outcome mea-
sures, her trajectory of recovery is predicted to be
strong. On the basis of her SPPB and quality of life data,
she had already returned to nearly 80% of her baseline
predicted physical function, except for slightly low gait
speed, fatigue, and endurance during ambulation. The
patient scored much higher (10/12 on SPPB) than previ-
ously reported data in an ICU follow-up clinic 1 month
after ICU discharge (5/12 in 36 patients) [12]. She did
not have signs or symptoms consistent with anxiety, de-
pression, or post-traumatic stress disorder (PTSD).
Compared with previously published ICU follow-up data
[5, 12], the patient would be considered at low risk of
developing PICS. However, considering her symptoms of
reduced respiratory endurance and muscle weakness
when performing the sit-to-stand test as well as her in-
creased likelihood of anxiety related to isolation and fre-
quent reminders of the pandemic [13, 14], she may
benefit from continued ICU follow-up.
Our ICU recovery clinic physical therapist and our
APRN educated the patient on exercise and activity at
home to improve her functional status. Sleep, nutrition,
and medications were addressed at both clinic appoint-
ments. The patient and her family were provided educa-
tion on the importance of extensive hand hygiene and
use of a face mask to reduce the likelihood of secondary
transmission in the home and in public [15], especially
given the reproductive number (R0) of COVID-19 [16].
In addition, education was provided on when to return
to work and to driving, which focused on a gradual pro-
gression, such as practicing driving in areas of less traffic
in and around her neighborhood and building up toler-
ance to full workload by starting part-time or modifying
her physical requirements at work. The patient did re-
port returning to driving as well as a modified work
schedule about 2 months after hospital discharge. In
addition, she was provided access to a shared ICU recov-
ery email with all team members able to respond to in-
quiries, should she have questions about her recovery.
The patient demonstrated significant improvements dur-
ing her short-term recovery, but, even 4 months after
discharge, she continues to have reduced endurance and
exercise capacity (64% predicted 6MWD) and infrequent
bouts of isolated anxiety and situational depression.
Thus, the patient and the clinic team developed a short-
term plan to have the patient continue to seek care in
the ICU recovery clinic with a long-term goal to estab-
lish a primary care provider in her city of residence.
Conclusion
We present this case report as a precursor to suggest
that patients surviving COVID-19 with subsequent
development of ARDS will require more intense ICU re-
covery follow-up. Even with her lower severity of illness
and less complex ICU course, our patient will still have
benefited from follow-up services and education to
maximize her outcomes. We suggest that patients with a
higher degree of acute illness who also have preexisting
comorbidities and who are of older age who survive
mechanical ventilation for COVID-19 will require sub-
stantial post-ICU care. Prior data of patients surviving
acute respiratory failure suggest that ICU COVID-19
survivors will have substantial difficulties with anxiety,
depression, PTSD, and physical disabilities as well as risk
of secondary neurologic and cardiac complications [17–
22]. Interdisciplinary follow-up care delivered using a re-
covery or PICS model will be of vital importance for
positive outcomes in this population.
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